Table 3 Obstetric and neonatal outcome
Total cohort | False positives | Misclassification | True positives | p1 | |
|---|---|---|---|---|---|
(n = 526) | (n = 39) | (n = 49) | (n = 438) | ||
% [m ± SD] | % [m ± SD] | % [m ± SD] | % [m ± SD] | ||
Year of birth | (n = 526) | (n = 39) | (n = 49) | (n = 438) | |
2006 | 22.5 | 17.0 | 26.6 | 22.5 | 0.49 |
2007 | 25.1 | 21.3 | 20.4 | 26.0 | |
2008 | 28.1 | 34.0 | 28.6 | 27.4 | |
2009 | 24.3 | 27.7 | 24.5 | 23.9 | |
Female | (n = 526) 45.9 | (n = 39) 44.7 | (n = 49) 48.9 | (n = 438) 45.7 | 0.89 |
Pregnancy outcome 2 | (n = 526) | (n = 39) | (n = 49) | (n = 438) | |
TOPFA< 21 weeks | 2.3 | 0 | 4.2 | 2.3 | 0.39 |
TOPFA ≥ 22 weeks | 20.8 | 0 | 31.3 | 21.9 | 0.0001 |
In utero fetal death | 2.5 | 0 | 2.1 | 2.7 | 0.50 |
Neonatal death | 2.7 | 2.1 | 2.1 | 2.7 | 0.94 |
Term at birth (weeks) | (n = 526) | (n = 39) | (n = 49) | (n = 438) | |
[35.5 ± 6.1] | [39.4 ± 1.9] | [34.2 ± 6.5] | [35.2 ± 6.2] | 0.001 | |
Weight (g) | (n = 526) | (n = 39) | (n = 49) | (n = 438) | |
[2588 ± 1134] | [3272 ± 525] | [2265 ± 1211] | [2551 ± 1147] | 0.001 | |
IUGR (3 rd Percentile) | (n = 482) | (n = 39) | (n = 44) | (n = 399) | |
4.9 | 2.1 | 9.1 | 4.8 | 0.03 | |
Height (cm) | (n = 526) | (n = 39) | (n = 49) | (n = 438) | |
[45.1 ± 7.7] | [49.3 ± 2.1] | [42.2 ±8.9] | [44.9 ±7.8] | 0.001 | |
Type of malformation | (n = 526) | (n = 39) | (n = 49) | (n = 438) | |
Single | 76.0 | 100 | 53.1 | 76.3 | 0.40 |
Multiple | 8.2 | 0 | 22.5 | 7.3 | |
Syndrome with normal karyotype | 4.3 | 0 | 8.2 | 4.3 | |
Chromosomal anomalies | 11.4 | 0 | 16.3 | 12.1 |